DVAX
Dynavax Technologies Corporation · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth -9.1% ·
share flow +5.9% ·
net new positions -10.0%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 3.00M | -2.9% | $33.43M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Renaissance Technologies ✦ | 2.31M | -6.6% | $25.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Millennium Management ✦ | 1.48M | -5.5% | $16.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 1.43M | +70.2% | $15.95M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Fisher Asset Management ✦ | 1.37M | -1.3% | $15.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 794.78K | +228.6% | $8.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 443.26K | +33.8% | $4.94M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | T. Rowe Price ✦ | 78.78K | -21.5% | $878,000 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 68.02K | New | $757,787 | 0.0% | New | 1 | SEC ↗ ×4 |
| 10 | Gotham Asset Management ✦ | 20.21K | -44.5% | $225,195 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $757,787 | 0.0% |
Exited
| Norges Bank | $2.65M | was 0.0% |
| Marshall Wace | $901,769 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 6 shares, $93 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.